Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

ゲンタミシンが誘発した双極前庭機能低下.

L B Minor1

  • 1Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Md 21203-6402, USA.

JAMA
|February 28, 1998
PubMed
まとめ

No abstract available in PubMed .

関連する実験動画

関連する概念動画

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Re: Response to Drs Carey et al.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2013
Same author

Re: Superior semicircular canal syndrome should be searching for an alternative pathology.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2013
Same author

Changes in the angular vestibulo-ocular reflex after a single dose of intratympanic gentamicin for Ménière's disease.

Annals of the New York Academy of Sciences·2002
Same author

Relationship between time- and frequency-domain analyses of angular head movements in the squirrel monkey.

Journal of computational neuroscience·2002
Same author

Superior canal dehiscence: mechanisms of pressure sensitivity in a chinchilla model.

Archives of otolaryngology--head & neck surgery·2001
Same author

Symptoms and signs in superior canal dehiscence syndrome.

Annals of the New York Academy of Sciences·2001
Same journal

Online Prescribing of GLP-1 Receptor Agonists.

JAMA·2026
Same journal

Using AI Disagreement to Expose Gaps in Coverage Rules.

JAMA·2026
Same journal

Randomized Trials in Pregnancy.

JAMA·2026
Same journal

Randomized Trials in Pregnancy-Reply.

JAMA·2026
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
関連記事をすべて見る